News

E-cigarettes precede tobacco smoking in ninth-graders

View on the News

E-cigarettes are not for young people

The study by Leventhal et al. presents the “strongest evidence to date” that e-cigarettes may pose a health hazard by encouraging adolescents to start smoking conventional tobacco products.

But regardless of whether e-cigarettes are a “gateway” drug, there is no reason for adolescents to use a product for which the purported intent is to help adults quit smoking. To protect youths, the same sales, marketing, and use restrictions that apply to combustible cigarettes should – promptly and effectively – be applied to e-cigarettes.

The Food and Drug Administration should set a minimum age of sale, require health warnings on e-cigarettes, and consider regulatory activities such as banning e-cigarette flavorings and prohibiting advertising in youth-oriented media. And states and communities should restrict e-cigarette smoking in public places and workplaces to avoid normalizing the behavior.

Nancy A. Rigotti, M.D., is in the department of medicine at Massachusetts General Hospital and Harvard Medical School, Boston. She reported receiving grants and nonfinancial support from Pfizer, and nonfinancial support from Arena Pharmaceuticals. Dr. Rigotti made these remarks in an editorial accompanying Dr. Leventhal’s report (JAMA 2015;314[7]:673-4).


 

FROM JAMA

References

Ninth-graders who have used electronic cigarettes are much more likely than are nonusers to try regular cigarettes, cigars, and hookahs during the subsequent year, according to a report published online Aug. 18 in JAMA.

E-cigarettes are handheld battery-operated devices that heat a liquid composed of nicotine, propylene glycol or glycerin, flavorings, and other chemicals to create a vapor that is inhaled, simulating the experience of cigarette smoking. Their main potential benefit is to help adult smokers switch from using the more unhealthy combustible tobacco.

However, critics argue that adolescents who use e-cigarettes may be more likely to try other products that deliver nicotine, which would perpetuate the current epidemic of tobacco-related illness, said Adam M. Leventhal, Ph.D., of the department of preventive medicine, University of Southern California, Los Angeles, and his associates.

©mauro grigollo/Thinkstock.com

The investigators analyzed data from a longitudinal survey of substance use and mental health among high school students. In their prospective observational study, they focused on 2,530 demographically diverse students in ninth grade at 10 Los Angeles–area public high schools. The students were nonsmokers at baseline. A total of 222 of these adolescents reported that they had used e-cigarettes, while 2,308 had not.

Adolescents who had used e-cigarettes were much more likely than were nonusers to report trying combustible tobacco products during the next 6 months (30.7% vs 8.1%) and during the next 12 months (25.2% vs 9.3%), for an odds ratio of 4.27 averaged across the two study periods. This association was strong for each of the combustible tobacco products assessed, with an OR of 2.65 for regular cigarettes, an OR of 4.85 for full-size cigars or cigarillos, and an OR of 3.25 for hookahs.

When the data were adjusted to account for many sociodemographic, environmental, and intrapersonal characteristics known to influence smoking, the ORs declined but the associations remained strong and statistically significant, ranging from 1.75 to 2.96, depending on the smoking product, Dr. Leventhal and his associates said (JAMA. 2015;314[7]:700-707). One possible explanation for these findings is that adolescents who used e-cigarettes enjoyed the experience and were more likely to experiment with other nicotine-containing products. However, “because this is an observational study, and one of the first to address this issue, inferences regarding whether this association is or is not causal cannot yet be made,” they noted.

Recommended Reading

More sensitive IPD definition improves vaccine cost-effectiveness
MDedge Family Medicine
Lung cancer biomarker moves into the clinic
MDedge Family Medicine
Hypertonic saline linked to modest drop in length of stay for bronchiolitis
MDedge Family Medicine
Proglycem found to increase pulmonary hypertension risk in infants
MDedge Family Medicine
Continuous albuterol is safe intermediate-care option in community hospitals
MDedge Family Medicine
What Matters: Sleep restriction
MDedge Family Medicine
Inpatient mortality down for high-volume conditions
MDedge Family Medicine
Mobile health technology may encourage behavioral change
MDedge Family Medicine
S. aureus seen in 1% of pediatric CAP cases
MDedge Family Medicine
In refractory asthma, think vocal cord dysfunction
MDedge Family Medicine